12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Amarin sales and marketing update

Amarin said it launched Vascepa icosapent ethyl in the U.S. as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia, defined as triglyceride levels of at least...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >